Although several lung cancer susceptibility loci have been identified, much of the heritability for lung cancer remains unexplained. Here 14,803 cases and 12,262 controls of European descent were genotyped on the OncoArray and combined with existing data for an aggregated genomewide association study (GWAS) analysis of lung cancer in 29,266 cases and 56,450 controls. We identified 18 susceptibility loci achieving genome-wide significance, including 10 new loci. The new loci highlight the striking heterogeneity in genetic susceptibility across the histological subtypes of lung cancer, with four loci associated with lung cancer overall and six loci associated with lung adenocarcinoma. Gene expression quantitative trait locus (eQTL) analysis in 1,425 normal lung tissue samples highlights RNASET2, SECISBP2L and NRG1 as candidate genes. Other loci include genes such as a cholinergic nicotinic receptor, CHRNA2, and the telomere-related genes OFBC1 and RTEL1. Further exploration of the target genes will continue to provide new insights into the etiology of lung cancer.
Lung cancer continues to be the leading cause of cancer mortality worldwide 1 . Although tobacco smoking is the main risk factor, the heritability of lung cancer has been estimated at 18% (ref. 2) . GWAS have previously identified several lung cancer susceptibility loci including CHRNA3, CHRNA5, TERT, the human leukocyte antigen (HLA) region, BRCA2 and CHEK2 (refs. 3,4) , but most of its heritability remains unexplained. With the goal of conducting a comprehensive characterization of common lung cancer genetic susceptibility loci, we undertook additional genotyping of lung cancer cases and controls using the OncoArray 5 genotyping platform, which queried 517,482 SNPs chosen for fine-mapping of susceptibility to common cancers as well as for de novo discovery (Online Methods and Supplementary Table 1 ). All participants gave informed consent, and each study obtained local ethics committee approval. After quality control filters (Online Methods), a total of 14,803 cases and 12,262 controls of European ancestry were retained and underwent imputation techniques to infer additional genotypes for genetic variants included in 1000 Genomes Project data (Online Methods). Logistic regression was then used to assess the association between variants (n = 10,439,017 SNPs) and lung cancer risk, as well as risk by predominant histological type and by smoking behavior (Online Methods). Fixed-effects models (Online Methods) were used to combine the OncoArray results with previously published lung cancer GWAS 3, 4, 6 , allowing for analysis of 29,266 patients and 56,450 controls of European descent ( Table 1) . There were no signs of genomic inflation overall or for any subtype ( Supplementary Fig. 1 ) indicating little evidence for confounding by cryptic population structure (Online Methods). All findings with a P value less than 1 × 10 −5 are reported in Supplementary Table 2 . As shown in Figure 1 , the genetic architecture of lung cancer varies markedly among the histological subtypes, with striking differences between lung adenocarcinoma and squamous cell carcinoma. Manhattan plots for small cell carcinoma (SCLC), ever and never smoking are displayed in Supplementary Figure 2 . The array heritability estimates were comparable among histological subsets, but squamous cell carcinoma appeared to share more genetic architecture with SCLC than with adenocarcinoma (Supplementary Table 3) . Table 2 presents summary results for all loci with a sentinel variant (defined as the variant with the lowest P value at each locus) that reached genome-wide significance (P < 5 × 10 −8 ) for lung cancer overall and by histological subtype. Sentinel variants stratified by new and previous genotyping and by additional statistical significance assessed on the basis of the number of effective tests, approximate Bayes factors and Bayesian false discovery probability are presented in Supplementary Tables 4 and 5, respectively. Repeat genotyping of 12% of the OncoArray-genotyped samples confirmed the fidelity of the genotyping or imputation for the risk loci and showed excellent concordance of imputation for SNPs with minor allele frequency (MAF) > 0.05 (Online Methods and Supplementary Note). Among the 18 loci that reached GWAS significance, 10 had not reached significance in previous genome-wide scans (Fig. 1) . Of these, four new loci were associated with lung cancer overall and six were associated with adenocarcinoma.
To decipher the association between these 18 loci and lung cancer risk, we further investigated their association with gene expression levels in normal lung tissues (n = 1,425) ( Supplementary Fig. 3 and Supplementary Table 6 ), genomic annotations (Supplementary Table 7 ) and smoking propensity (cigarettes smoked per day (n = 91,046) and Fagerström test for nicotine dependence (FTND) metrics (n = 17,074)) ( Table 2) . Previous studies have shown shared risk for lung cancer and chronic obstructive pulmonary disease (COPD) through inflammation and reactive oxygen species (ROS) pathways 7 ; therefore, we also assessed the association between sentinel SNPs and reduced lung capacity through spirometry measurements (forced expiratory volume in 1 s (FEV 1 ), forced vital capacity (FVC), n = 30,199) ( Table 2 and Online Methods).
Variants at four new loci (1p31.1, 6q27, 8p21 and 15q21.1) were associated with lung cancer risk overall, with little evidence for heterogeneity among subtypes ( Supplementary Fig. 4 ). The 1p31.1 locus, recently identified in a pathway-based analysis of the TRICL data 8 , represented by rs71658797 (odds ratio (OR) = 1.14, 95% confidence interval (CI) = 1.09-1.18, P = 3.25 × 10 −11 ), is located near FUBP1-DNAJB4 (Supplementary Fig. 4 ). At 6q27, rs6920364 was associated with lung cancer risk with an OR of 1.07 (95% CI = 1.05-1.10, P = 1.3 × 10 −8 ) with little heterogeneity found by smoking status (Supplementary Fig. 4 ). This locus is predicted to regulate RNASET2 ( Supplementary Fig. 5 and Supplementary Table 7) . We identified rs6920364 as a lung cis-eQTL for RNASET2, which encodes an extracellular RNase, in all five cohorts tested (Supplementary Table 6) , with increased lung cancer risk correlating with increased RNASET2 expression (Fig. 2) . Variants correlated with rs6920364 (r 2 > 0.88) have been noted in GWAS of Crohn's disease and inflammatory bowel disease [9] [10] [11] [12] [13] .
The 8p21 locus has been suggested as a lung cancer susceptibility locus by pathway analysis 14 and is now confirmed at the level of GWAS significance. It is a complex locus represented by sentinel variant rs11780471 associated with lung cancer (OR = 0.87, 95% CI = 0.83-0.91, P = 1.69 × 10 −8 ) (Supplementary Fig. 4 ), but this region contained additional uncorrelated variants (pairwise r 2 < 0.10) associated with lung cancer (Supplementary Table 8) . Multivariate analysis was consistent with multiple susceptibility alleles at this locus (Supplementary Table 8 ). In contrast to expression in lung tissue (Fig.  3a, Supplementary Fig. 3 and Supplementary Table 6), we noted that the alleles associated with lung cancer tended to be associated with cerebellum expression of CHRNA2, a member of the cholinergic nicotinic receptor (Fig. 3b) . The cis-eQTL effect of rs11780471 on CHRNA2 in the brain was limited to the cerebellum (Fig. 3c) , a region not traditionally linked to addictive behavior but where an emerging role in this behavior is suggested 15 . We therefore investigated rs11780471 in the context of smoking behavior (Supplementary Note). Unlike the well-described 15q25.1 (rs55781567) CHRNA5 locus ( Table 2) , rs11780471 was not associated with number of cigarettes smoked per day or the FTND metrics (Fig. 3d) . Nevertheless, carriers of the risk allele for lung cancer at rs11780471 tended to be smokers and initiated smoking at earlier ages (Fig. 3d) , implying that this variant's association with lung cancer could potentially be mediated by its influencing aspects of smoking behavior. Another potentially relevant gene in this region is EPHX2, a xenobiotic metabolism gene. Some of the 8p21 variants associated with lung cancer were cis-eQTLs for EPHX2 in lung tissues (for example, rs146729428, P = 1.77 × 10 −7 (Supplementary Table 2 ) and P = 5 × 10 −4 for lung cancer risk and eQTL activity, respectively), but in general we did not observe a clear relationship between the alleles associated with lung cancer and those associated with EPHX2 expression levels (Supplementary Table 8 ). Nevertheless, a potential synergistic role for EPHX2 and CHRNA2 in lung cancer etiology cannot be excluded. l e t t e r s 1 1 2 8 VOLUME 49 | NUMBER 7 | JULY 2017 Nature GeNetics l e t t e r s
The genetic locus at 15q21 (rs66759488) was shown to be associated with lung cancer overall (OR = 1.07, 95% CI = 1.05-1.10, P = 2.83 × 10 −8 ) and across lung cancer histologies ( Supplementary Fig. 4 ). Genomic annotation suggests that genetic variants correlated with rs66759488 may influence the SEMA6D gene (Supplementary Table 7) , but there was no clear eQTL effect (Supplementary Table 6 ) and this variant did not appear to have a major influence on smoking propensity or lung function ( Table 2) .
For specific lung cancer histology subtypes, we identified six new loci associated with lung adenocarcinoma (15q21, 8p12, 10q24, 20q13.33, 11q23.3 and 9p21.3) ( Table 2) . The locus at 15q21 (rs77468143, OR = 0.86, 95% CI = 0.83-0.89, P = 1.7 × 10 −16 ) is predicted to target SECISBP2L ( Supplementary Fig. 5 ), and expression analysis indicated rs77468143 to be a cis-eQTL for SECISBP2L in lung tissue in all eQTL cohorts tested (Supplementary Table 6 ). The genetic risk allele appears to correlate with decreased expression levels of SECISBP2L ( Fig. 2 and Supplementary Fig. 5 ), an observation that is consistent with SECISBP2L being downregulated in lung cancers 16 . ) is colored according to the degree of LD (r 2 ) with the sentinel lung cancer-associated variant (marked) at that locus. The association between the sentinel variant and lung cancer (or a histological subtype) is shown as well as the eQTL evidence in lung epithelium for the Microarray study (Ex.Array; Laval, UBC and Groningen) and RNA-seq data sets (NCI and GTEx). At 6q27, 15q21.1 and 8p12, the variants associated with lung cancer also tend to be those that are cis-eQTLs in lung for RNASET2, SECISBP2L and NRG1, respectively. At 11q23.3, while the sentinel variant (rs1056562) is a cis-eQTL in lung for AMICA1, additional variants are cis-eQTLs for AMICA1 in lung but are not associated with lung adenocarcinoma, and vice versa, suggesting that an alternate candidate gene may be responsible for this association or that there may be a pleiotropic effect at this locus. l e t t e r s rs77468143 was nominally associated with lung function (Table 2) , potentially implicating inflammation of the lung as part of the mechanism at this locus.
At 8p12, expression analysis indicated that the alleles associated with lung adenocarcinoma (represented by the sentinel variant rs4236709 ( Table 2) ) also appear to be a lung cis-eQTL for the NRG1 gene ( Supplementary Fig. 5 and Supplementary Table 6 ). This region also contains putative regulatory sites (Supplementary Fig. 5 ). Somatic translocations of NRG1 are infrequently observed in lung adenocarcinomas 17 . While somatic translocations at 8p12 generally take place in never-smokers and are linked with ectopic activation of NRG1, rs4236709 was associated with lung cancer in both ever-and never-smokers ( Supplementary Fig. 4) , and its genetic risk allele correlated with decreased NRG1 expression (Fig. 2) . Interestingly, 6q22.1 variants located near ROS1, another gene somatically translocated in lung adenocarcinoma and for which nearby germline variants were associated with never-smoking lung adenocarcinoma in Asian women 18 , were associated with lung adenocarcinoma at borderline genome-wide significance (rs9387479, OR = 0.92, 95% CI = 0.89-0.95, P = 6.57 × 10 −8 ) (Supplementary Table 2) .
Three of the sentinel variants associated with lung adenocarcinoma are located near genes related to telomere regulation: rs11591710 (10q24) and rs41309931 (20q13.33) near OBFC1 and RTEL1, respectively, and rs7705526 near TERT, as previously noted 19, 20 . The variants at 10q24 associated with lung adenocarcinoma also appear to be associated with telomere length (Supplementary Fig. 6 ). By contrast and consistent with observations of 20q13.33 variants associated with glioma 21 , the variants associated with telomere length at 20q13. 33 were not necessarily those associated with lung adenocarcinoma (Supplementary Fig. 6 ). Nevertheless, more generally, the variants associated by GWAS with longer telomere length 22 appear linked with risk of lung adenocarcinoma 23 and glioma 21, 24 , a finding consistent with our expanded analysis here (Supplementary Fig. 6) .
We additionally identified a complex locus at 11q23.3. The sentinel variant rs1056562 (OR = 1.11, 95% CI = 1.07-1.14, P = 2.8 × 10 −10 ) is more prominently associated with lung adenocarcinoma VOLUME 49 | NUMBER 7 | JULY 2017 Nature GeNetics l e t t e r s (Supplementary Fig. 4) . rs1056562 was correlated with expression of two genes at this locus, AMICA1 and MPZL3 (Supplementary Table 6 ). However, there did not appear to be a consistent relationship between the alleles related to AMICA1 and MPZL3 gene expression and those associated with lung adenocarcinoma (Fig. 2 and Supplementary Table 9 ), suggesting that expression of these genes alone is unlikely to mediate this association. At 9p21.3, we identified rs885518 that appeared to be associated with lung adenocarcinoma (OR = 1.17, 95% CI = 1.11-1.23, P = 1.0 × 10 −9 ). 9p21.3 is a region containing CDNK2A and variants associated with multiple cancer types, including lung cancer. Nevertheless, rs885518 is located approximately 200 kb centromeric to the previously described variants (Supplementary Fig. 4 ) and shows little evidence for linkage disequilibrium (LD) (all pairwise r 2 < 0.01) with rs1333040, a variant previously associated with lung squamous cell carcinoma 3 , and rs62560775, another variant suggested to be associated with lung adenocarcinoma 25 that we confirm at genome-wide significance here. These variants appear to confer predominant associations with different lung cancer histologies, suggesting that they are independent associations (Supplementary Fig. 7) .
Aside from the clear smoking-related effects on lung cancer risk through the CHRNA5 and CYP2A6 regions and association with CHRNA2 noted above, the rest of the variants we have identified do not appear to clearly influence smoking behaviors ( Table 2) , implying that these associations are likely mediated by other mechanisms. Nevertheless, there is shared genetic architecture between smoking behavior and lung cancer risk, consistent with the notion that genetic variants do also influence lung cancer risk through behavioral mechanisms (Supplementary Fig. 8 ).
In conclusion, the genetic susceptibility alleles we describe here explain approximately 12.3% of the familial relative risk previously reported in family cancer databases 26, 27 , of which 3.5% was accounted for by the new loci. Our findings emphasize striking heterogeneity across histological subtypes of lung cancer. We expect that further exploration of the related target genes of these susceptibility loci, as well as validation and identification of new loci, will continue to provide insights into the etiology of lung cancer.
URLs. OncoArray, http://epi.grants.cancer.gov/oncoarray/ and http:// oncoarray.dartmouth.edu/; FastPop, http://sourceforge.net/projects/ fastpop/; PLINK, http://zzz.bwh.harvard.edu/plink/; IMPUTE2, http://mathgen.stats.ox.ac.uk/impute/impute_v2.html; SHAPEIT, https://mathgen.stats.ox.ac.uk/genetics_software/shapeit/shapeit. html; GTEx, http://www.gtexportal.org/home/; Braineac, http:// braineac.org/; Tobacco and Genetics (TAG) consortium, https://www. med.unc.edu/pgc/downloads.
METHOdS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
comPetIng FInAncIAl InteRests
The authors declare competing financial interests: details are available in the online version of the paper.
Reprints and permissions information is available online at http://www.nature.com/ reprints/index.html. Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. eQTL analysis of lung cancer sentinel variants. To investigate the association between the sentinel variants and mRNA expression, we used three different eQTL data sets: (i) the Microarray eQTL study, (ii) the NCI RNA-seq eQTL study and (iii) GTEx. In the Microarray eQTL study, lung tissues for eQTL analysis were obtained from patients who underwent lung surgery at three academic sites: Laval University, the University of British Columbia (UBC) and the University of Groningen. Whole-genome gene expression profiling in the lung was performed on a custom Affymetrix array (GPL10379). Microarray preprocessing and quality control have been described previously 34 . Genotyping was carried out on the Illumina Human 1M-Duo BeadChip array. Genotypes and gene expression levels were available for 409, 287 and 342 patients at Laval, UBC and Groningen, respectively. In the NCI RNA-seq eQTL study, RNA was extracted from lung tissue samples in the Environment and Genetics in Lung Cancer Etiology (EAGLE) study. RNA-seq was carried out on 90 lung tissue samples obtained from an area distant from the tumor (defined here as 'non-malignant lung tissue') to minimize the potential for local cancer field effects. Transcriptome sequencing for the 90 non-tumor samples was performed on the Illumina HiSeq 2000 or 2500 platform with 100-bp paired-end reads. Genotyping was undertaken using Illumina BeadChips as described previously 35 . In GTEx, eQTL summary statistics based on RNA-seq analysis were obtained from the GTEx data portal (see URLs; ref. 36 ). Data were available for lung tissue in 278 individuals. Details of these three eQTL studies are provided in the Supplementary Note.
The Microarray eQTL study was used as a discovery cohort. Probe sets located within 2-Mb regions centered on lung cancer-associated SNPs were considered for cis-eQTL analyses. We also explored a 5-Mb interval on both sides of lung cancer-associated SNPs that did not act as eQTLs in lung tissue within the 2-Mb window. For each sentinel variant, the top eQTL association (or multiple eQTLs that each had P < 0.0005) was considered. This eQTL was then assessed specifically in the independent NCI and GTEx RNA-seq eQTL data sets. Statistical significance was defined by the eQTL surpassing locusspecific Bonferroni correction in the discovery cohort (P = 0.05/number of probes at the locus) and subsequently showing evidence of replication in the validation cohorts (NCI and GTEx RNA-seq data sets).
Lung cancer susceptibility variants in other phenotypes. We assessed associations between sentinel genetic variants associated with lung cancer and other phenotypes, including smoking behavior, FTSD score, lung function and telomere length. Additional details on these analyses for other phenotypes are provided in the Supplementary Note.
Smoking behavior. The effects of lung cancer sentinel variants on smoking behavior were assessed by meta-analysis across three studies: ever-smoking controls with intensity information from the OncoArray studies (n = 8,120), deCODE (n = 40,882) and UK Biobank (n = 42,044). Association with nicotine dependence was evaluated using FTND data collected in four studies (n = 17,074)-deCODE, EAGLE, the Collaborative Genetic Study of Nicotine Dependence (COGEND) and the Study of Addiction: Genetics and Environment (SAGE)-and from current smokers in one other study (Chronic Obstructive Pulmonary Disease Gene (COPDGene)). Study-specific SNP association results were combined using fixed-effects, inverse-variance-weighted meta-analysis with genomic control applied. Specifically, for the 8p21 variant rs11780471, we additionally considered other aspects of smoking behavior data from UK Biobank, deCODE and OncoArray controls. We additionally included summary statistics for the rs11780471 variant from the TAG consortium (described in detail in the Supplementary Note).
Lung function. Lung function in silico lookup was conducted in data from the SpiroMeta consortium, which included 38,199 European-ancestry individuals. Genome-wide association between genetic variants and FEV 1 , FVC and FEV 1 /FVC was assessed in the 38,199 individuals with 1000 Genomes Project (phase 1)-imputed genotypes 37 .
Telomere length. Sentinel genetic variants associated with telomere length were those described by Codd et al. 22 . Telomere lengths in 6,766 individuals were obtained from UK Studies of Epidemiology and Risk Factors in Cancer Heredity (SEARCH) study controls using a real-time PCR methodology and genotyping as described in Pooley et al. 38 .
Genetic heritability and correlations. Genome-wide SNP heritability and correlation estimates were obtained using association summary statistics and LD information through LD score (LDSC) regression analyses 39, 40 . These analyses were restricted to HapMap 3 SNPs with MAF >5% in European populations from the 1000 Genomes Project. The association summary statistics used for these analyses were based on lung cancer histology and smoking type (lung cancer overall, adenocarcinoma, squamous cell carcinoma, SCLC, ever-smokers and never-smokers) and smoking behavior parameters (CPD, smoking status (ever-versus never-smoker) and smoking cessation (current versus former smoker)) from the TRICL-ILCCO OncoArray consortium and the Tobacco and Genetics (TAG) consortium (see URLs) 41 .
Estimating the percentage of familial relative risk explained. The familial relative risk to a first-degree relative accounted for by an individual variant (denoted as λ i ) was estimated on the basis of the relative risk per allele and the allele frequency for that variant, using the method described in Hemminki et al. 42 and Bahcall 43 , under the assumption of a log-additive effect. Assuming the effects of all susceptibility variants combine multiplicatively and not in LD, the combined effect (λ T ) can then be expressed as the product of all λ i . The proportion of the familial relative risk attributable to the totality of the susceptibility variants can then be computed as log(λ T )/log(λ P ). λ P is the familial relative risk observed in the epidemiological studies, and it is approximately 2.0 for lung cancer on the basis of family cancer databases 26, 27 . The percentage reported is based on the 18 sentinel variants reported in Table 2 . Multiple independent alleles in the same loci were not taken into account for this estimation.
Data availability. The data sets generated during the current study are available at the database of Genotypes and Phenotypes (dbGaP) under accession phs001273.v1.p1. Data from previous GWAS meta-analyses contributing to this study are available under accession phs000876.v1.p1.
The OncoArray data deposited at dbGaP include data excluded from the analyses presented in this paper to avoid overlap with previous studies. Readers interested in obtaining a copy of the original data can do so by completing the proposal request form at http://oncoarray.dartmouth.edu/.
Cluster plots of all SNPs on the OncoArray can be obtained at http:// oncoarray.dartmouth.edu/.
